SLSN

Solesence, Inc. Common Stock

4.07 USD
-0.05
1.21%
At close Jun 13, 4:00 PM EDT
1 day
-1.21%
5 days
3.56%
1 month
4.36%
3 months
127.37%
6 months
127.37%
Year to date
127.37%
1 year
127.37%
5 years
127.37%
10 years
127.37%
 

About: Solesence Inc is a scientifically driven health care solutions company across beauty and life science categories, protecting skin from environmental aggressors and enhancing the aesthetic appeal of healthy products. The group is engaged in the beauty category that develops and manufactures clean, inclusive, mineral-based skincare and makeup products at the forefront of skin health. Its brands are Stress Defense, Kleair, and Bloom.

Employees: 98

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

100% less funds holding

Funds holding: 1 [Q4 2024] → 0 (-1) [Q1 2025]

100% less capital invested

Capital invested by funds: $30K [Q4 2024] → $0 (-$30K) [Q1 2025]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Research analyst outlook

We haven’t received any recent analyst ratings for SLSN.

Financial journalist opinion

Neutral
GlobeNewsWire
1 week ago
Solésence Expands Debt Facilities to Fuel Growth Initiatives
ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives.
Solésence Expands Debt Facilities to Fuel Growth Initiatives
Neutral
Seeking Alpha
1 month ago
Solesence, Inc. (SLSN) Q1 2025 Earnings Conference Call Transcript
Solesence, Inc. (NASDAQ:SLSN ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Jess Jankowski - President & CEO Kevin Cureton - COO Conference Call Participants Operator Good day and thank you for standing by. Welcome to the Solesence First Quarter 2025 Conference Call.
Solesence, Inc. (SLSN) Q1 2025 Earnings Conference Call Transcript
Neutral
GlobeNewsWire
1 month ago
Solésence Reports Record First Quarter 2025 Financial Results
First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025.
Solésence Reports Record First Quarter 2025 Financial Results
Neutral
GlobeNewsWire
1 month ago
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date.
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
Charts implemented using Lightweight Charts™